Breaking Finance News

Tekmira Shares Spike After Confirmed US Ebola Case

EbolaShares of Tekmira Pharmaceuticals, which is working on a treatment for Ebola, soared in after hours trading after the Centers for Disease Control confirmed the first case of Ebola in the US.

Tekmira (NASDAQ: TKMR)  jumped 27% to $26.82 on very heavy volume following the report from the CDC.

Ebola is believed to have sickened more than 6,500 people in West Africa, and more than 3,000 people have died

Yesterday, Texas Health Presbyterian Hospital of Dallas issued a statement that a patient was placed in a “strict isolation” and was tested for Ebola virus due to his symptom and recent travel history.

Tekmira was not the only company to see a rise on stock price.

Shares of Inovio Pharmaceuticals Inc. shares rose 35 cents, or 3.6 percent, to $10.20 in aftermarket trading, while NewLink Genetics Corp. shares gained $2.68, or 12.5 percent, to $24.10.

Stock of some other companies that have been involved in efforts to come up with vaccines and medications also jumped. BioCryst Pharmaceuticals Inc. added $1.26, or 13 percent, to $11.04; Sarepta Therapeutics Inc. rose $1.57, or 7.4 percent, to $22.67; and Tekmira Pharmaceuticals Corp. stock climbed $5.97, or 28 percent, to $27.11.

Ebola’s symptoms can start as much as 21 days after exposure, and the disease isn’t contagious until symptoms begin. It takes close contact with bodily fluids to spread.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.